These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31607910)

  • 1. Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects.
    Ohno Y; Kunisawa N; Shimizu S
    Front Pharmacol; 2019; 10():1045. PubMed ID: 31607910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice.
    Shimizu S; Mizuguchi Y; Sobue A; Fujiwara M; Morimoto T; Ohno Y
    J Pharmacol Sci; 2015 Apr; 127(4):439-45. PubMed ID: 25850380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders.
    Tatara A; Shimizu S; Shin N; Sato M; Sugiuchi T; Imaki J; Ohno Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):252-9. PubMed ID: 22542492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms.
    Shimizu S; Mizuguchi Y; Tatara A; Kizu T; Andatsu S; Sobue A; Fujiwara M; Morimoto T; Ohno Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():86-91. PubMed ID: 23838274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics.
    Calsolaro V; Femminella GD; Rogani S; Esposito S; Franchi R; Okoye C; Rengo G; Monzani F
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33803277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for pharmacotherapy in Alzheimer's disease - A primer on FDA-approved drugs.
    Varadharajan A; Davis AD; Ghosh A; Jagtap T; Xavier A; Menon AJ; Roy D; Gandhi S; Gregor T
    J Neurosci Rural Pract; 2023; 14(4):566-573. PubMed ID: 38059250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E; Ligori LD
    J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Perception and Treatment Options for Behavioral and Psychological Symptoms of Dementia (BPSD) in Italy.
    D'Antonio F; Tremolizzo L; Zuffi M; Pomati S; Farina E;
    Front Psychiatry; 2022; 13():843088. PubMed ID: 35432010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD).
    Liperoti R; Pedone C; Corsonello A
    Curr Neuropharmacol; 2008 Jun; 6(2):117-24. PubMed ID: 19305792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).
    Bucki A; Marcinkowska M; Śniecikowska J; Zagórska A; Jamrozik M; Pawłowski M; Głuch-Lutwin M; Siwek A; Jakubczyk M; Pytka K; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Mierzejewski P; Kołaczkowski M
    Eur J Med Chem; 2020 Apr; 191():112149. PubMed ID: 32105980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress.
    Magierski R; Sobow T; Schwertner E; Religa D
    Front Pharmacol; 2020; 11():1168. PubMed ID: 32848775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice.
    Yabuki Y; Matsuo K; Hirano K; Shinoda Y; Moriguchi S; Fukunaga K
    Pharmacology; 2017; 99(3-4):160-171. PubMed ID: 28049192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions.
    Shimizu S; Mizuguchi Y; Ohno Y
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):861-9. PubMed ID: 23844689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors.
    Ohno Y; Imaki J; Mae Y; Takahashi T; Tatara A
    Neuropharmacology; 2011; 60(2-3):201-8. PubMed ID: 20813116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.